This study provides a comprehensive exploration of ALDH1A3’s multifaceted impact on breast cancer, elucidating its roles in CSC maintenance and tumor heterogeneity, EMT and MET, and metabolic reprogramming. This evidence concerns the gene ALDH1A3 and breast cancer.